Patrick Campbell

Released on Jan. 10, the latest scientific statement from the American Heart Association details gaps in cardiovascular risk management impacting the majority of patients with type 2 diabetes within the US.

A recent analysis found patients with benign adrenal tumors and MACS were at an increased risk of cardiometabolic diseases.

A comparison of data from patients with mild to moderate COVID-19 provides insight into the long-term effects on cardiac, renal, pulmonary, and thrombotic function status.

An analysis of data from 1860 mother-child pairs suggests presence of abnormal maternal thyroid hormone levels could help in the prediction of behavioral and emotional health problems in male offspring at 4 years of age.

New research published in Circulation Research suggests investigators at Northwestern Medicine have developed and validated sex- and race-specific equations for calculating lifetime risk of incident heart failure.

A cross-sectional study of more than 1000 patients suggests presence of MACS in patients with benign adrenal tumors was associated with increased prevalence and severity of hypertension as well as an increase in the likelihood of requiring insulin therapy in type 2 diabetes.

An analysis of data from more than 1.1 million patients provides an overview of inequities in use of GLP-1 RAs among patients with diabetes based on racial/ethnic background and household income.

The American Academy of Neurology released guidelines detailing oral and topical treatment options for management of painful diabetic neuropathy on December 27.

Announced on December 30, the approval of levoketoconazole (Recorlev), a cortisol synthesis inhibitor, is for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative.

New research published in the Journal of the American Heart Association provides an overview of the changes in the rate of premature death due to acute myocardial infarction among patients in the US younger than 65 years of age.

A trial comparing changes in blood glucose before, during, and after exercise at sea level and simulated altitude provides insight into the potential increase in risk for hypoglycemia among patients with type 1 diabetes.

A new trial from Wake Forest University underlines the importance of messaging and individualized approaches to achieve weight loss among older patients with obesity.

Announced on Dec. 20, the US FDA awarded approval to the Sapien 3 with Alterra from Edwards Lifesciences Corporation for pediatric and adult patients with severe pulmonary regurgitation.

The American Diabetes Association has released their 2022 Standards of Medical Care in Diabetes, which includes updates or additional guidance in areas such as diabetes screenings, first-line therapies, and technology use.

Announced on Dec. 20, the latest approvals for rivaroxaban (Xarelto) mark the 10th and 11th indications for the factor Xa inhibitor in the US.

An analysis of data from the PURE study suggests those with high stress levels had a 22% greater risk of cardiovascular disease, a 24% greater risk of congestive heart disease, and a 30% greater risk of stroke compared to their counterparts with no stress.

Implicity announced their ILR ECG Analyzer received 510(k) clearance from the FDA in a statement released on December 16.

An umbrella review of meta-analyses of RCTs examining intermittent fasting for weight loss provide a comprehensive overview of the effects of the approach on various health outcome measures in patients with overweight or obesity.

An analysis of the Women's Health Initiative suggests hypertensive disorders of pregnancy were associated with a significant increase in risk for incident heart failure, but this association was not observed for other adverse pregnancy outcomes.

An analysis of Medicare fee-for-service data from 2017-2019 details the widening gaps in access to newer diabetes technologies for non-White patients in the US.

Released on Dec. 15, the latest scientific statement from the American Heart Association provides a comprehensive overview of the available evidence on topics related to diagnosis, management, and pharmacotherapy for hypertension during pregnancy.

A retrospective analysis of data from more than 170 patients with Cushing syndrome and hyperglycemia provides insight into the effects of curative treatment on hyperglycemia among these patients.

An analysis of data from the Women's Health Initiative suggests a history of hypertensive disorders of pregnancy was associated with an almost doubling in odds of developing heart failure later in life.

Data from an analysis of 67k older Danes suggests statin discontinuation corresponded with 1 excess event per 112 persons per year in a primary prevention cohort and 1 excess event per 77 persons per year in a secondary prevention cohort.

The ACC/AHA/SCAI 2021 guideline recommendations for coronary artery revascularization were released on December 9, which they hope will replace or retire recommendations from half a dozen previous guidelines.

An analysis of more than 25k patients using levothyroxine demonstrates the impact of appointment delays on TSH levels among these patients.

Analysis of data from the SOS study indicates bariatric surgery was associated with a 37% reduction in incident cancer among individuals with obesity and diabetes versus conventional obesity treatments, with those achieving diabetes remission experiencing a 60% reduction in risk.

A retrospective analysis of patients with suspected myocarditis following COVID-19 vaccination provides clinicians with insight into the disease course, treatment, and imaging findings among this patient population.

A report published in Circulation details per month increases in both systolic and diastolic blood pressure observed during the pandemic as compared with prepandemic periods.